Assignee
CLS THERAPEUTICS LTD
GB·10 granted patents·9 pending applications·123 citations·filing 2013–2025
Top patents by PatentIndex Score
19 records- 0196US9845461B2Method for treating oncological diseasesCLS THERAPEUTICS LTD·Filed 2016·Granted Dec 19, 2017·14 cites·4 claims
- 0296US9248166B2Method for treating oncological diseasesCLS THERAPEUTICS LTD·Filed 2014·Granted Feb 2, 2016·20 cites·4 claims
- 0396US8535663B2Method for treating delayed-type hypersensitivityCLS THERAPEUTICS LTD·Filed 2013·Granted Sep 17, 2013·28 cites·3 claims
- 0495US9770492B2Method for treating systemic DNA mutation diseaseCLS THERAPEUTICS LTD·Filed 2016·Granted Sep 26, 2017·17 cites·5 claims
- 0595US8796004B2Method for treating systemic DNA mutation diseaseCLS THERAPEUTICS LTD·Filed 2013·Granted Aug 5, 2014·20 cites·4 claims
- 0693US9072733B2Method for treating systemic bacterial, fungal and protozoan infectionCLS THERAPEUTICS LTD·Filed 2013·Granted Jul 7, 2015·12 cites·2 claims
- 0792US10617743B2Method to improve safety and efficacy of anti-cancer therapyCLS THERAPEUTICS LTD·Filed 2015·Granted Apr 14, 2020·6 cites·15 claims
- 0886US9463223B2Method for monitoring development of somatic mosaicismCLS THERAPEUTICS LTD·Filed 2014·Granted Oct 11, 2016·4 cites·5 claims
- 0980US2025064901A1Method to improve safety and efficacy of anti-cancer therapyCLS THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 1079US11905522B2Treatment of diseases by liver expression of an enzyme which has a deoxyribonuclease (DNase) activityCLS THERAPEUTICS LTD·Filed 2019·Granted Feb 20, 2024·1 cites·6 claims
- 1176US11701410B2Extracellular DNA as a therapeutic target in neurodegenerationCLS THERAPEUTICS LTD·Filed 2016·Granted Jul 18, 2023·1 cites·30 claims
- 1268US2024245758A1Immunomodulation of tumor microenvironmentCLS THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 1367US2017056482A1Method for treating systemic dna mutation diseaseCLS THERAPEUTICS LTD·Filed 2016·Application pending·0 cites
- 1466US2020188493A1Method to improve safety and efficacy of anti-cancer therapyCLS THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 1566US2026083827A1Immunomodulation of tumor microenvironmentCLS THERAPEUTICS LTD·Filed 2025·Application pending·0 cites
- 1655US2024050476A1Combination of deoxyribonuclease enzyme and cell therapies for treatment of cancerCLS THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 1754US2015110769A1Method for retarding unhealthy manifestations brought by ageing of human beingsCLS THERAPEUTICS LTD·Filed 2014·Application pending·0 cites
- 1852US2022241394A1TREATMENT OF DISEASES ASSOCIATED WITH PROTEIN MISFOLDING BY NERVOUS SYSTEM EXPRESSION OF AN ENZYME WHICH HAS A DEOXYRIBONUCLEASE (DNase) ACTIVITYCLS THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 1942US2017100463A1Method to improve safety and efficacy of anti-cancer therapyCLS THERAPEUTICS LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CLS THERAPEUTICS LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →